Cisplatin, cisplatinum, platamin, neoplatin, cismaplat or cis-diamminedichloridoplatinum(II) (CDDP) is a chemotherapy drug. It was the first member of a class of Platinum-containing anti-cancer drugs, which now also includes Carboplatin and Oxaliplatin. These platinum complexes react in the body, binding to DNA and causing the DNA strands to crosslink, which ultimately triggers cells to die in a programmed way. (https://en.wikipedia.org/wiki/Cisplatin)

Incoming Links #

Related Articles (Article 0) #

• Chemotherapy
• Triple-negative breast cancer

Related Medical Scholarly Articles (MedicalScholarlyArticle 1) #

• Triple-negative breast cancer: an unmet medical need

Suggested Pages #

• 0.640 Paclitaxel
• 0.090 Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
• 0.079 BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
• 0.035 Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
• 0.034 CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
• 0.031 Copy-number variation
• 0.016 Comparative analysis of algorithms for identifying amplifications and deletions in array CGH data
• 0.012 Cattle
• 0.012 Tumorscape
• 0.011 METABRIC
• More suggestions...